Human Milk Oligosaccharides

The HMO platform offerings allow you to formulate products and solutions that provide important health outcomes in infants, kids and adults, supported by emerging preclinical and clinical data.

Part of our purpose-led promise

Human Milk Oligosaccharides are a collection of carbohydrate structures and the third most abundant solid component of human milk after lipids and lactose. Clinical data in infants indicate that HMOs may help to develop the desired microbiota by serving as a food source for the good bacteria in the intestine. Naturally occurring in breast milk, HMOs have evolved over thousands of years, with clinical and preclinical HMO studies now suggesting that specific HMOs at the correct level of supplementation can provide us with unique health benefits. In particular, they may help support immunity and gut health, with a potential role in cognitive development, which may open future innovation opportunities.

GlyCare™ Human Milk Oligosaccharides

Next-generation HMOs are part of our exciting innovation roadmap, with four new HMOs becoming available this year for innovation trials to further catalyze the already fast-growing HMO market.

GlyCare™ 2FL

GlyCare™ LNnT

GlyCare™ 2FL/DFL

Glycare™ LNT

GlyCare™ 3SL

GlyCare™ 6SL

GlyCare™ LNFP I

GlyCare™ 3FL

Making more variants available

There are around 200 different types of human milk oligosaccharides. Our research and development team are developing a pipeline that represents more than 75% of all HMOs.

In our research and development team, consisting of more than 30 employees, we utilize our unique combination of biotechnology and bioengineering excellence with carbohydrate chemistry expertise to develop safe, rapid and cost-effective production processes of HMOs. Our strong analytical teams support the R&D program with its in-process control and final product method development expertise.

Extensive experience in Analytical Standards

Our team has developed analytical standards for HMOs for more than 10 years. We have gained extensive experience in production of HMOs with chemical and enzymatical synthesis and fermentation technology as part of our development of commercial HMOs. The analytical standards have had key importance for our ability to quality test and control our own products.

Clinical Research and Science

To prove the impact on human health and document the mechanisms of Human Milk Oligosaccharides (HMOs), we lead a rich program of preclinical and clinical studies. Independently, and along with a substantial network of more than 40 research and strategic partners across the world.

Furthermore, we are specifically investigating the effect of our HMOs on obese children and on patients suffering from irritable bowel syndrome (IBS) in blinded and placebo-controlled clinical studies.

Customized Solutions

Customized Services

Human Milk Oligosaccharides

Part of our purpose-led promise

GlyCare™ Human Milk Oligosaccharides

GlyCare™ 2FL

GlyCare™ LNnT

GlyCare™ 2FL/DFL

Glycare™ LNT

GlyCare™ 3SL

GlyCare™ 6SL

GlyCare™ LNFP I

GlyCare™ 3FL

Making more variants available

Extensive experience in Analytical Standards

Clinical Research and Science

Our Quality Guarantee

FS 22000 Certification

ISO 9001

SMETA four pillar

Related Articles

More than ingredients

I'd like to explore...

My job role is...

I Would Like to Discuss...

Title of Parent Label (Not Authorable)